Autres langues Cuu Long Pharmaceutical

Actions

DCL

VN000000DCL1

Produits pharmaceutiques

Cours en clôture Ho Chi Minh S.E. 12/10/2026			Varia. 5j.	Varia. 1 janv.
47 500,00 ^VND	-2,66%		+1,06%	+10,47%

17/09	Cuu Long Pharmaceutical Joint Stock Company annonce la démission de Duc Trong Nguyen de son poste de directeur général adjoint, effective au 26 septembre 2026	CI
03/08	Cuu Long Pharmaceutical Joint Stock Company publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI

Autres langues

17/09	Cuu Long Pharmaceutical Joint Stock Company Announces Resignation of Duc Trong Nguyen as Deputy General Director, Effective September 26, 2026
03/08	Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
03/08	Cuu Long Pharmaceutical Joint Stock Company to the Terminate Branch Operations: Kien Giang and Gia Lai
28/04	Cuu Long Pharmaceutical Joint Stock Company Provides Consolidated Earnings Guidance for the Year 2026
27/04	Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2026
28/01	Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
29/12	Cuu Long Pharmaceutical Joint Stock Company Announces Termination of Operation of Nghe an Branch
16/12	Cuu Long Pharmaceutical Joint Stock Company Announces Termination of Soc Trang Branch Operation
02/12	Cuu Long Pharmaceutical Joint Stock Company Appoints Subhash Kesavan Nair as Deputy General Director, Effective December 1, 2025
28/10/25	Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
19/09/25	Cuu Long Pharmaceutical Joint Stock Company Announces Change of Head Office Address
19/09/25	Cuu Long Pharmaceutical Joint Stock Company Announces Change in the 28th Certificate of Enterprise Registration
29/07/25	Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
29/04/25	Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2025
29/04/25	Cuu Long Pharmaceutical Joint Stock Company Announces Executive Changes, Effective May 1, 2025
24/01/25	Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2024
04/12/24	Cuu Long Pharmaceutical Joint Stock Company Announces Resignation of Nguyen Ba the as Chief Operating Officer
02/12/24	Cuu Long Pharmaceutical Joint Stock Company Announces Executive Changes
22/11/24	Cuu Long Pharmaceutical Joint Stock Company Announces Resignation of Nghiem Xuan Truong as Deputy CFO
30/10/24	Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
10/09/24	Cuu Long Pharmaceutical Joint Stock Company Announces Executive Changes
31/07/24	Cuu Long Pharmaceutical Joint Stock Company Announces Change in Chief Executive Officer
30/07/24	Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
26/07/24	Cuu Long Pharmaceutical Joint Stock Company Receives the Certificate of Branch Operation Registration by the Planning and Investment Department of Ho Chi Minh City
25/07/24	Cuu Long Pharmaceutical Joint Stock Company Announces Resignation of Luong Trong Hai as CEO, Effective August 01, 2024